Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Jennifer Michelle Trujillo

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-Administration
Phone303/724-2624

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ferdinand KC, Norris KC, Rodbard HW, Trujillo JM. Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review. Diabetes Ther. 2023 Dec; 14(12):1979-1996. PMID: 37751142.
      View in: PubMed
    2. Galindo RJ, Trujillo JM, Low Wang CC, McCoy RG. Advances in the management of type 2 diabetes in adults. BMJ Med. 2023; 2(1):e000372. PMID: 37680340.
      View in: PubMed
    3. Whitley HP, Trujillo JM, Neumiller JJ. Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clin Diabetes. 2023; 41(3):467-473. PMID: 37456085.
      View in: PubMed
    4. Trujillo JM, Cain J. Simplifying the PharmD Curriculum. Am J Pharm Educ. 2023 07; 87(7):100029. PMID: 37380263.
      View in: PubMed
    5. Tall Bull S, Nuffer W, Trujillo JM. Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist. J Diabetes Complications. 2022 12; 36(12):108332. PMID: 36375235.
      View in: PubMed
    6. Wettergreen SA, Stewart MP, Kennedy K, Trujillo JM. Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 Diabetes. Diabetes Spectr. 2023; 36(1):5-13. PMID: 36818408.
      View in: PubMed
    7. Wright EE, Malone DC, Trujillo JM, Gill J, Huse S, Li X, Zhou FL, Preblick R, Reid T. Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin. J Manag Care Spec Pharm. 2022 Jun; 28(6):592-603. PMID: 35352995.
      View in: PubMed
    8. Trujillo JM, Nuffer W, Smith BA. GLP-1 receptor agonists: an updated review of head-to-head clinical studies. Ther Adv Endocrinol Metab. 2021; 12:2042018821997320. PMID: 33767808.
      View in: PubMed
    9. Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline. Ann Intern Med. 2020 11 17; 173(10):813-821. PMID: 32866414.
      View in: PubMed
    10. Trujillo J. Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes. J Clin Pharm Ther. 2020 Sep; 45 Suppl 1:43-60. PMID: 32910487.
      View in: PubMed
    11. Lowe RN, Trujillo JM. Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies. Ann Pharmacother. 2020 08; 54(8):780-787. PMID: 32052651.
      View in: PubMed
    12. Anderson SL, Beutel TR, Trujillo JM. Oral semaglutide in type 2 diabetes. J Diabetes Complications. 2020 04; 34(4):107520. PMID: 31952996.
      View in: PubMed
    13. Rudolph M, Gortney JS, Brownfield A, Caldwell D, Castleberry A, Le UM, Medina MS, Sease JM, Trujillo J, Welch AC, Daugherty KK. Student perceptions of the utility of the Pharmacy Curriculum Outcomes Assessment. Curr Pharm Teach Learn. 2020 03; 12(3):255-264. PMID: 32273060.
      View in: PubMed
    14. Nuffer W, Williams B, Trujillo JM. A review of sotagliflozin for use in type 1 diabetes. Ther Adv Endocrinol Metab. 2019; 10:2042018819890527. PMID: 31807264.
      View in: PubMed
    15. Turrin KB, Trujillo JM. Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy. Diabetes Ther. 2019 Aug; 10(4):1337-1346. PMID: 31148053.
      View in: PubMed
    16. Patel D, Triplitt C, Trujillo J. Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist. Adv Ther. 2019 05; 36(5):1031-1051. PMID: 30900198.
      View in: PubMed
    17. Zhou AY, Trujillo JM. Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices. Diabetes Spectr. 2018 Nov; 31(4):359-366. PMID: 30510393.
      View in: PubMed
    18. Trujillo JM, Roberts M, Dex T, Chao J, White J, LaSalle J. Low incidence of gastrointestinal adverse events over time with a fixed-ratio combination of insulin glargine and lixisenatide versus lixisenatide alone. Diabetes Obes Metab. 2018 11; 20(11):2690-2694. PMID: 29923298.
      View in: PubMed
    19. Tuchscherer RM, Thompson AM, Trujillo JM. Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes. Ann Pharmacother. 2018 12; 52(12):1224-1232. PMID: 29932006.
      View in: PubMed
    20. Pearson SM, Trujillo JM, McDermott MT. 5-alpha-dihydrotestosterone elevations associated with phentermine use. Ther Adv Endocrinol Metab. 2018; 9(8):255-258. PMID: 30181851.
      View in: PubMed
    21. Johnson EL, Frias JP, Trujillo JM. Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgrad Med. 2018 May; 130(4):365-374. PMID: 29569978.
      View in: PubMed
    22. Pearson SM, Trujillo JM. Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements. Ther Adv Endocrinol Metab. 2018 Apr; 9(4):113-121. PMID: 29619208.
      View in: PubMed
    23. Nuffer W, Guesnier A, Trujillo JM. A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products. Ther Adv Endocrinol Metab. 2018 Mar; 9(3):69-79. PMID: 29492243.
      View in: PubMed
    24. Anderson SL, Trujillo JM, Anderson JE, Tanenberg RJ. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgrad Med. 2018 Mar; 130(2):229-238. PMID: 29260929.
      View in: PubMed
    25. Trujillo JM, Goldman J. Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes. Pharmacotherapy. 2017 Aug; 37(8):927-943. PMID: 28556176.
      View in: PubMed
    26. Goldman J, Trujillo JM. iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes. Ann Pharmacother. 2017 Nov; 51(11):990-999. PMID: 28645216.
      View in: PubMed
    27. Saseen JJ, Linnebur SA, Borgelt LM, Trujillo J, Fish DN, Mueller S. A Pharmacotherapy Capstone Course to Target Student Learning and Programmatic Curricular Assessment. Am J Pharm Educ. 2017 Apr; 81(3):45. PMID: 28496265.
      View in: PubMed
    28. Haines ST, Pittenger AL, Stolte SK, Plaza CM, Gleason BL, Kantorovich A, McCollum M, Trujillo JM, Copeland DA, Lacroix MM, Masuda QN, Mbi P, Medina MS, Miller SM. Core Entrustable Professional Activities for New Pharmacy Graduates. Am J Pharm Educ. 2017 02 25; 81(1):S2. PMID: 28289312.
      View in: PubMed
    29. Trujillo JM, Nuffer WA. Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes. Pharmacotherapy. 2017 Apr; 37(4):481-491. PMID: 28102030.
      View in: PubMed
    30. Trujillo JM, McNair CD, Linnebur SA, Valdez C, Trujillo TC. The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes. Am J Pharm Educ. 2016 Dec 25; 80(10):174. PMID: 28179723.
      View in: PubMed
    31. Haines ST, Gleason BL, Kantorovich A, McCollum M, Pittenger AL, Plaza CM, Stolte SK, Trujillo JM. Report of the 2015-2016 Academic Affairs Standing Committee. Am J Pharm Educ. 2016 Nov 25; 80(9):S20. PMID: 28090115.
      View in: PubMed
    32. Trujillo JM, Wettergreen SA, Nuffer WA, Ellis SL, McDermott MT. Cardiovascular Outcomes of New Medications for Type 2 Diabetes. Diabetes Technol Ther. 2016 12; 18(12):749-758. PMID: 27835045.
      View in: PubMed
    33. Anderson SL, Trujillo JM. Basal Insulin Use With GLP-1 Receptor Agonists. Diabetes Spectr. 2016 Aug; 29(3):152-60. PMID: 27574369.
      View in: PubMed
    34. Thompson AM, Trujillo JM. Advances in the treatment of type 2 diabetes: impact of dulaglutide. Diabetes Metab Syndr Obes. 2016; 9:125-36. PMID: 27217788.
      View in: PubMed
    35. Nuffer W, Trujillo JM, Megyeri J. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Ann Pharmacother. 2016 May; 50(5):376-88. PMID: 26887340.
      View in: PubMed
    36. Anderson SL, Trujillo JM. Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness. Ther Adv Chronic Dis. 2016 Jan; 7(1):4-17. PMID: 26770666.
      View in: PubMed
    37. Nuffer WA, Trujillo JM. Liraglutide: A New Option for the Treatment of Obesity. Pharmacotherapy. 2015 Oct; 35(10):926-34. PMID: 26497479.
      View in: PubMed
    38. Trujillo JM, Figler TA. Teaching and learning health literacy in a doctor of pharmacy program. Am J Pharm Educ. 2015 Mar 25; 79(2):27. PMID: 25861108.
      View in: PubMed
    39. Hildreth KL, Van Pelt RE, Moreau KL, Grigsby J, Hoth KF, Pelak V, Anderson CA, Parnes B, Kittelson J, Wolfe P, Nakamura T, Linnebur SA, Trujillo JM, Aquilante CL, Schwartz RS. Effects of pioglitazone or exercise in older adults with mild cognitive impairment and insulin resistance: a pilot study. Dement Geriatr Cogn Dis Extra. 2015 Jan-Apr; 5(1):51-63. PMID: 25852732.
      View in: PubMed
    40. Trujillo JM, Nuffer W, Ellis SL. GLP-1 receptor agonists: a review of head-to-head clinical studies. Ther Adv Endocrinol Metab. 2015 Feb; 6(1):19-28. PMID: 25678953.
      View in: PubMed
    41. Thompson AM, Trujillo JM. Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes. Ann Pharmacother. 2015 Mar; 49(3):351-9. PMID: 25565404.
      View in: PubMed
    42. Trujillo JM, Nuffer W. GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents. Pharmacotherapy. 2014 Nov; 34(11):1174-86. PMID: 25382096.
      View in: PubMed
    43. Nuffer W, Trujillo JM, Ellis SL. Technosphere insulin (Afrezza): a new, inhaled prandial insulin. Ann Pharmacother. 2015 Jan; 49(1):99-106. PMID: 25313261.
      View in: PubMed
    44. Trujillo JM, Nuffer W. Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes. Ann Pharmacother. 2014 Nov; 48(11):1494-501. PMID: 25136065.
      View in: PubMed
    45. Trujillo JM, Saseen JJ, Linnebur SA, Borgelt LM, Hemstreet BA, Fish DN. Impact of student- versus instructor-directed case discussions on student performance in a pharmacotherapy capstone course. Am J Pharm Educ. 2014 Apr 17; 78(3):56. PMID: 24761017.
      View in: PubMed
    46. King WM, McDermott MT, Trujillo JM. Initial management of severe hyperglycemia in patients with type 2 diabetes: an observational study. Diabetes Ther. 2013 Dec; 4(2):375-84. PMID: 23949906.
      View in: PubMed
    47. Hume AL, Kirwin J, Bieber HL, Couchenour RL, Hall DL, Kennedy AK, LaPointe NM, Burkhardt CD, Schilli K, Seaton T, Trujillo J, Wiggins B. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy. 2012 Nov; 32(11):e326-37. PMID: 23108810.
      View in: PubMed
    48. Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71. PMID: 22825226.
      View in: PubMed
    49. DiVall M, Barr J, Gonyeau M, Matthews SJ, Van Amburgh J, Qualters D, Trujillo J. Follow-up assessment of a faculty peer observation and evaluation program. Am J Pharm Educ. 2012 May 10; 76(4):61. PMID: 22611270.
      View in: PubMed
    50. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010 May; 44(5):904-9. PMID: 20371755.
      View in: PubMed
    51. Trujillo J. A drug interactions elective course. Am J Pharm Educ. 2009 Jul 10; 73(4):72. PMID: 19657505.
      View in: PubMed
    52. Trujillo JM, Hardy Y. A Nutrition Journal and Diabetes Shopping Experience to improve pharmacy students' empathy and cultural competence. Am J Pharm Educ. 2009 Apr 07; 73(2):37. PMID: 19513175.
      View in: PubMed
    53. Trujillo JM, DiVall MV, Barr J, Gonyeau M, Van Amburgh JA, Matthews SJ, Qualters D. Development of a peer teaching-assessment program and a peer observation and evaluation tool. Am J Pharm Educ. 2008 Dec 15; 72(6):147. PMID: 19325963.
      View in: PubMed
    54. Trujillo JM, Barsky EE, Greenwood BC, Wahlstrom SA, Shaykevich S, Pendergrass ML, Schnipper JL. Improving glycemic control in medical inpatients: a pilot study. J Hosp Med. 2008 Jan; 3(1):55-63. PMID: 18257047.
      View in: PubMed
    55. Gonyeau MJ, Trujillo J, DiVall M. Development of progressive oral presentations in a therapeutics course series. Am J Pharm Educ. 2006 Apr 15; 70(2):36. PMID: 17139337.
      View in: PubMed
    56. Trujillo JM, Gonyeau MJ, DiVall MV, Alexander SL. Spironolactone use in patients with heart failure. J Clin Pharm Ther. 2004 Apr; 29(2):165-70. PMID: 15068406.
      View in: PubMed
    Trujillo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (157) concept(s)
    _
    Co-Authors Expand Description
    See all (19) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)